v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Operating activities:    
Net loss $ (20,673) $ (4,317)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization expense 12,101 12,625
Bad debt expense 1,017 589
Stock-based compensation expense 37,091 34,335
Amortization of operating lease right-of-use assets 6,471 6,739
Adjustments to contingent consideration 607 0
Other, net (751) 351
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in a business acquisition:    
Accounts receivable 55,285 57,251
Prepaid expenses and other current assets (74) (2,738)
Costs to obtain revenue contracts 10,476 9,054
Other long term assets 256 542
Accounts payable, accrued expenses and other current liabilities 7,181 (9,175)
Unearned revenue (89,117) (78,434)
Operating lease liabilities (8,312) (8,892)
Other long term liabilities 307 207
Net cash provided by operating activities 11,865 18,137
Investing activities:    
Capital expenditures (1,769) (2,320)
Cash paid in acquisition, net of cash acquired (89,407) 0
Net cash used in investing activities (91,176) (2,320)
Financing activities:    
Proceeds from exercise of stock options 1,137 8,770
Repurchase of common stock (6,760) (23,086)
Payments for taxes related to net share settlement of stock-based compensation awards (9,031) (10,718)
Payments of deferred financing costs (777) (394)
Proceeds, net from employee stock purchase plan withholdings 2,218 2,546
Net cash used in financing activities (13,213) (22,882)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 345 (993)
Net decrease in cash, cash equivalents and restricted cash (92,179) (8,058)
Cash, cash equivalents and restricted cash at beginning of period 210,184 190,214
Cash, cash equivalents and restricted cash at end of period $ 118,005 $ 182,156

Source

HTML PDF
ZIP